The turnover of pharmaceutical preparations in Germany showed considerable fluctuations from 2013 to 2023, with a notable drop in 2017 followed by a significant surge in 2018. The year 2023 saw the turnover at 111.34 billion Euros. In recent years, the sector exhibited robust growth, as reflected by the year-on-year variations of 10.18% in 2022 and 9.15% in 2023. The average annual growth rate over the past five years was 8.16%, indicating resilience and an upward trajectory.
Going forward, forecasts predict continued growth in the pharmaceutical preparations sector, with an expected turnover reaching 156.63 billion Euros by 2028. The projected 5-year compound annual growth rate is 5.37%, with an overall growth rate of 29.89% over the same period.
Future trends to watch for include:
- Technological advancements in drug development and production.
- Increased investment in healthcare infrastructure and services.
- Emerging markets and evolving regulatory landscapes.
- Focus on innovative treatments and personalized medicine.
